Swiss drugmaker Roche Holding AG's oral chemotherapy drug Xeloda,or capecitabine, proved inferior to standard chemotherapy intreating older women with early stage breast cancer, a studyreleased on Saturday at a major meeting of oncology specialistsfound.
More...